Summary of findings table ‐ Concizumab prophylaxis vs on‐demand therapy
Annualized Bleeding Rate (ABR), All bleeds · people with inhibitors
1 finding from 1 review
- Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 68 participantsLow